Hematological integrated indicators in assessing the cellular reactivity of the body in COVID-19 coronavirus infection

  • Raisa M. Smolyakova International Sakharov Environmental Institute, Belarusian State University
  • Helena А. Kozyreva International Sakharov Environmental Institute, Belarusian State University
  • Katsiaryna M. Shpadaruk International Sakharov Environmental Institute, Belarusian State University

Abstract

The article analyzes the disorders in homeostasis diagnosed during the development of acute viral infection SARS-CoV-2 in patients. Hematological changes in patients with coronavirus infection were characterized by the development of disintegration of humoral mechanisms of regulation with the initiation of a systemic inflammatory reaction with an increase in the leukocyte index of intoxication, activation of necrobiotic processes, an increase in the activity of macrophage-microphage nonspecific protection with a predominance of effector links of the immunological process. The development of immunocompromise in patients with a new strain of coronavirus infection is one of the determining factors in the course of the disease.

Author Biographies

Raisa M. Smolyakova, International Sakharov Environmental Institute, Belarusian State University

doctor of sciences (biological), professor; professor of the department of general biology and genetics, faculty of environmental medicine

Helena А. Kozyreva, International Sakharov Environmental Institute, Belarusian State University

graduate student of the faculty of environmental medicine

Katsiaryna M. Shpadaruk, International Sakharov Environmental Institute, Belarusian State University

PhD (biology), docent; associate professor of the department of general biology and genetics, faculty of environmental medicine

References

1. Novel coronavirus – Thailand (ex-China). WHO [Интернет; процитировано 19 января 2020 г]. Доступно по: http://www.who.int/csr/don/14-january-2020-novel-coronavirusthailand/en/
2. Chen Yu, Qianyun Liu, Guo Deyin. Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of Medical Virology. 2020;92 (4):418–423.
3. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [published online ahead of print, 2020 February 03]. Nature. 2020. DOI: 10.1038/s41586-020-2012-7.
4. Geng L, Fan Y, Lai Y et.al. Coronavirus infections and immune responses. Journal of Medical Virology. 2020;92:424–432.
5. Hoffmann M, Kleine-Weber H, Krueger N, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells [published online ahead of print, 2020 January 31]. bioRxiv. 2020. DOI: org/10.1101/2020.01.31.929042.
6. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online, 2020 February 07]. JAMA. DOI: 10.1001/jama.2020.1585.
7. Pan Luo, Dong Liu*, Juan Li. Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19. International Journal of Antimicrobial Agents [published online, 2020 April 29]. DOI: 10.36233/0507-4088-2020-65-1-6-15.
8. Смолякова РМ. Клеточные тесты реактивности и показатели интоксикации в оценке гнойно-воспалительных осложнений у онкологических больных. Медицинская панорама. 2004;5:11–14.
Published
2021-04-09
Keywords: SARS-CoV-2 coronavirus infection, homeostasis, cellular composition of peripheral blood, integral hematological parameters of the body’s cellular reactivity
How to Cite
Smolyakova, R. M., KozyrevaH. А., & Shpadaruk, K. M. (2021). Hematological integrated indicators in assessing the cellular reactivity of the body in COVID-19 coronavirus infection. Journal of the Belarusian State University. Ecology, 1, 77-84. Retrieved from https://journals.bsu.by/index.php/ecology/article/view/3884